Biotech Nephrogen Combines AI and Gene Therapy to Reverse Kidney Disease
Biotech Nephrogen combines AI and gene therapy to reverse kidney disease, offering breakthrough hope for patients with chronic renal conditions.
Matilda
Biotech Nephrogen Combines AI and Gene Therapy to Reverse Kidney Disease
Biotech Nephrogen combines AI and gene therapy to reverse kidney disease—a bold innovation reshaping how genetic kidney disorders are treated. Founded by Demetri Maxim, who was inspired by his mother’s struggle with kidney failure, Nephrogen is pioneering an AI-powered system that delivers gene-editing medicines directly to damaged kidney cells. The approach marks a major leap from symptom management toward complete disease reversal. Image Credits:Svisio / Getty Images How Does Biotech Nephrogen Use AI to Reverse Kidney Disease? Nephrogen’s groundbreaking technology harnesses artificial intelligence to design delivery systems that can transport CRISPR-based therapies precisely where they are needed. Its AI platform analyzes countless molecular patterns, finding the safest and most efficient ways to target kidney cells. According to Maxim, the company’s delivery mechanism is 100 times more efficient than currently approved treatments, creating new possibilities for restoring kidney functi…